Metropolis Healthcare Ltd. Fundamental & Technical Research, Share Price Today

NSE : METROPOLIS
NIFTY : Nifty 500
NIFTY SECTOR : Nifty Healthcare Index

About Company

Metropolis Healthcare Limited is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.

Market Cap. ₹8,436 Cr.

52 Week - High/Low ₹2,318/1,315

P/E Ratio 61.84

P/B Ratio 7.96

Enterprise Value ₹8,409 Cr.

ROE % 11.87

RSI Value 93.69

EMA 50 1537.46

EMA 200 1528.5

Net Profit 116 Cr.

Net Profit 3year growth -36.55 Cr.

Net Profit 3 year (back) 183 Cr.

Debt to Equity 0.0 %

EPS Growth TTM -12.91 %

Current Ratio 1.14 %

100 Day SMA 1,845 Rs.

200 Day SMA 1,980 Rs.

21 Day SMA 1,585 Rs.

50 Day SMA 1,656 Rs.

Book Value 201 Rs.

EV/EBITDA Ratio 28

QoQ EPS Growth -35 %

QoQ Operating Profit Growth -21 %

QoQ Sales Growth -8 %

Sales Latest Quarter 297 Cr.

YoY Sales Growth 10 %

Market Cap. ₹8,436 Cr.

52 Week - High/Low ₹2,318/1,315

P/E Ratio 53.89

P/B Ratio 7.49

Enterprise Value ₹8,515 Cr.

ROE % 12.42

RSI Value 93.69

EMA 50 1537.46

EMA 200 1528.5

Net Profit 128 Cr.

Net Profit 3year growth -3.1 Cr.

Net Profit 3 year (back) 183 Cr.

Debt to Equity 0.0 %

EPS Growth TTM -9.38 %

Current Ratio 1.25 %

100 Day SMA 1,845 Rs.

200 Day SMA 1,980 Rs.

21 Day SMA 1,585 Rs.

50 Day SMA 1,656 Rs.

Book Value 214 Rs.

EV/EBITDA Ratio 26

QoQ EPS Growth -33 %

QoQ Operating Profit Growth -20 %

QoQ Sales Growth -8 %

Sales Latest Quarter 323 Cr.

YoY Sales Growth 11 %

Add Parameters

Valuation

Peer Comparison

Industry - Hospital & Healthcare Services

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages